Mesoblast Limited
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $161.6M | $63.0M | $71.3M | $60.4M | $136.9M | $129.3M | $50.4M | $37.8M |
| Accounts Receivable | $13.9M | $1.4M | $2.3M | $2.2M | $2.0M | $678.0K | $1.7M | $6.6M |
| Inventory | $22.2M | $0 | — | — | — | — | — | — |
| Total Current Assets | $204.4M | $86.5M | $81.7M | $69.8M | $148.2M | $136.5M | $62.5M | $101.1M |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $784.7M | $669.2M | $669.4M | $662.1M | $744.7M | $733.6M | $652.1M | $692.4M |
| Liabilities | ||||||||
| Accounts Payable | $19.1M | $7.1M | $20.1M | $23.1M | $19.6M | $25.0M | $13.1M | $18.9M |
| Total Current Liabilities | $102.6M | $73.2M | $42.0M | $51.4M | $94.3M | $90.1M | $44.3M | $24.0M |
| Long-Term Debt | $67.7M | $100.5M | $102.8M | $91.6M | $41.0M | $57.0M | $67.3M | $59.4M |
| Total Liabilities | $187.2M | $188.8M | $167.6M | $165.1M | $163.3M | $184.3M | $171.1M | $146.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.01B | $-908.8M | $-820.8M | $-738.9M | $-647.6M | $-548.8M | $-470.0M | $-380.2M |
| Total Stockholders' Equity | $597.4M | $480.4M | $501.8M | $497.0M | $581.4M | $549.3M | $481.1M | $546.0M |